Issue 40 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

21

No.

40

October 20, 1995Oct 20, 1995

Free

DOWNLOAD THE PDF

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

In Brief: Goldman Named Director, Albert Einstein Cancer Center; Wiernik Resumes Post

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

Petition Filed To Revoke NlH License To Use Radioactive Materials

Extramural Advisory Board Members Listed

Komen Foundation Awards New Grants

Recent Issues

Volume 52 | Issue 19 - May 15, 2026

Volume 52 | Issue 18 - May 08, 2026

Volume 52 | Issue 17 - May 01, 2026

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026